ANTICOAGULANT THERAPY
Clinical trials for ANTICOAGULANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new ANTICOAGULANT THERAPY trials appear
Sign up with your email to follow new studies for ANTICOAGULANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood thinner trial aims to prevent rebleeding in liver patients
Disease control Not yet recruitingThis study tests whether the blood thinner rivaroxaban can safely improve outcomes in people with liver cirrhosis who have both a blood clot in the portal vein and a high risk of variceal bleeding. About 175 participants will receive rivaroxaban or standard care starting 48 hours…
Matched conditions: ANTICOAGULANT THERAPY
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Heart study tests safer blood thinner for High-Risk patients
Disease control Not yet recruitingThis study compares two blood thinners, bivalirudin and heparin, used during a heart procedure called PCI in people with acute coronary syndrome who are at high risk of bleeding. About 5,270 participants will be randomly assigned to receive one of the two drugs. The goal is to se…
Matched conditions: ANTICOAGULANT THERAPY
Phase: PHASE4 • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC